Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

Clinical trial NCT07418138 · COMPLETED

Trial details

NCT number: NCT07418138
Sponsor: Hu Liangshuo
Status: COMPLETED
Study type: OBSERVATIONAL

Liver Transplantation Hepatocellular Carcinoma (HCC)Tyrosine Kinase Inhibitor Survival Rate

Start date: 2015-01-01
Primary completion: 2024-12-31
Enrollment: 484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.